Achieve Life Sciences Shares Fall After FDA Inspection Finds Violations

Dow Jones
Apr 15

By Christopher Kuo

 

Achieve Life Sciences shares fell after the Food and Drug Administration found that one of its third-party facilities requires regulatory or administrative action.

Shares of the pharmaceutical company fell 5.1% on Wednesday to $3.43. Achieve Life's shares are down 31% year to date.

After inspecting one of the company's third-party manufacturing facilities, the FDA designated the facility under its most severe classification category, Official Action Indicated, which often means a facility is not compliant with regulations.

Achieve Life said the FDA classification is related to manufacturing practices at the facility and not to its drug, cytisinicline.

 

Write to Christopher Kuo at chris.kuo@wsj.com

 

(END) Dow Jones Newswires

April 15, 2026 11:33 ET (15:33 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10